Get the Stockscreener App
411.49
2.26%
9.11
After Hours:
411.49
Idexx Laboratories Inc stock is traded at $411.49, with a volume of 965.43K.
It is up +2.26% in the last 24 hours and down -2.57% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
See More
Previous Close:
$402.38
Open:
$405.45
24h Volume:
965.43K
Relative Volume:
1.23
Market Cap:
$32.79B
Revenue:
$3.90B
Net Income/Loss:
$887.87M
P/E Ratio:
38.57
EPS:
10.67
Net Cash Flow:
$798.08M
1W Performance:
+7.77%
1M Performance:
-2.57%
6M Performance:
-10.55%
1Y Performance:
-13.96%
1-Day Range:
$402.86
$412.62
1-Week Range:
$375.06
$412.62
52-Week Range:
$356.14
$548.88
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
411.49 | 32.79B | 3.90B | 887.87M | 798.08M | 10.67 |
|
TMO
Thermo Fisher Scientific Inc
|
427.50 | 169.62B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
186.83 | 138.06B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
102.48 | 29.99B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
143.91 | 26.61B | 15.41B | 1.37B | 2.11B | 7.50 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
Morgan Stanley Adjusts IDEXX Laboratories' Price Target to $548 From $559, Keeps Overweight Rating - MarketScreener
Idexx Laboratories (IDXX): Morgan Stanley Adjusts Price Target, Maintains Overweight Rating | IDXX Stock News - GuruFocus
Stifel Adjusts Price Target for Idexx Laboratories (IDXX) Amidst Innovation Analysis | IDXX Stock News - GuruFocus
Stifel Adjusts IDEXX Laboratories' PT to $420 From $450, Keeps Hold Rating - MarketScreener
IDEXX Laboratories: I Love The Business, Not The Stock Price (NASDAQ:IDXX) - Seeking Alpha
IDEXX (IDXX) Surges 10.0%: Is This an Indication of Further Gains? - Yahoo Finance
IDEXX Laboratories (NasdaqGS:IDXX) Price Moves -14% Over The Last Week Amid Market Volatility - Yahoo Finance
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock - Yahoo Finance
Should You Sell IDEXX Laboratories (IDXX)? - MSN
How Is The Market Feeling About IDEXX Laboratories? - Benzinga
IDEXX Laboratories to Release 2025 First Quarter Financial Results - 01net
US judge dismisses most of consumer lawsuit over veterinary service prices - Reuters
We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease - simplywall.st
Meet the Little-Known S&P 500 Stock That Has Rocketed 10,230% Higher Since 2000 - Yahoo Finance
Form DEF 14A IDEXX LABORATORIES INC For: Dec 31 - StreetInsider.com
Howe & Rusling Inc. Buys New Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Is IDEXX Laboratories, Inc. (IDXX) The Best Pet Stock to Buy According to Billionaires? - Insider Monkey
8 Best Pet Stocks to Buy According to Billionaires - Insider Monkey
Why IDEXX Laboratories, Inc. (IDXX) is Among the Best Diagnostics Stocks to Invest in Right Now - Insider Monkey
IDEXX Laboratories Insiders Sell US$1.9m Of Stock, Possibly Signalling Caution - Yahoo Finance
12 Best Diagnostics Stocks to Invest In Right Now - Insider Monkey
Idexx's Economic Moat Remains Solid, but Softer Consumer Confidence Could Weigh on Near Term - Morningstar
Should You Retain IDEXX Stock in Your Portfolio for Now? - TradingView
IDEXX Laboratories: Cancer Dx Launch In March 2025; Upgrading To ‘Buy’ (NASDAQ:IDXX) - Seeking Alpha
Is IDEXX Laboratories Stock Underperforming the Nasdaq? - Nasdaq
The total return for IDEXX Laboratories (NASDAQ:IDXX) investors has risen faster than earnings growth over the last five years - Simply Wall St
Is IDEXX Laboratories Stock Underperforming The Nasdaq? - Barchart
Jones Financial Companies Lllp Sells 194 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Defense World
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory - Insider Monkey
Two Texas solar plants serve four buyers through energy attribute certificates - pv magazine USA
X-ELIO closes six US PPAs with Cisco, Biogen, IDEXX, and Waters Corporation - Morningstar
IDEXX Laboratories: A Top Dog In The Pet Care Market (NASDAQ:IDXX) - Seeking Alpha
Steward Partners Investment Advisory LLC Purchases 218 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Defense World
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Oppenheimer & Co. Inc. - Defense World
IDEXX Laboratories, Inc. to Host Earnings Call - ACCESS Newswire
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Purchased by Assetmark Inc. - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Cut to Hold at StockNews.com - Defense World
Idexx (IDXX) Down 5% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
FFT Wealth Management LLC Makes New $227,000 Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Illinois Municipal Retirement Fund Sells 1,017 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Sigma Planning Corp - MarketBeat
738 Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Bought by JFG Wealth Management LLC - MarketBeat
Amalgamated Bank Sells 684 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Upgraded by StockNews.com to "Buy" Rating - MarketBeat
Sterling Investment Advisors Ltd. Buys New Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Fjarde AP Fonden Fourth Swedish National Pension Fund Raises Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Sabal Trust CO Makes New Investment in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Wealthspire Advisors LLC Sells 1,358 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Idexx Laboratories Inc Stock (IDXX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Smith Martin Alexander | Executive Vice President |
Feb 14 '25 |
Option Exercise |
0.00 |
1,231 |
0 |
1,766 |
| Schreck Michael | Executive Vice President |
Feb 14 '25 |
Option Exercise |
0.00 |
1,459 |
0 |
2,397 |
| MAZELSKY JONATHAN JAY | President and CEO |
Feb 14 '25 |
Option Exercise |
0.00 |
2,747 |
0 |
84,505 |
| Lane Michael | Executive Vice President |
Feb 14 '25 |
Option Exercise |
0.00 |
885 |
0 |
7,375 |
| Johnson Michael Perkins | Executive Vice President |
Feb 14 '25 |
Option Exercise |
0.00 |
355 |
0 |
585 |
| Hunt Nimrata | Executive Vice President |
Feb 14 '25 |
Option Exercise |
0.00 |
872 |
0 |
12,595 |
| FENNELL GEORGE | Executive Vice President |
Feb 14 '25 |
Option Exercise |
0.00 |
304 |
0 |
8,480 |
| Erickson Michael G | Executive Vice President |
Feb 14 '25 |
Option Exercise |
0.00 |
557 |
0 |
21,393 |
| Erickson Michael G | Executive Vice President |
Feb 11 '25 |
Option Exercise |
67.85 |
1,544 |
104,760 |
20,836 |
| FENNELL GEORGE | Executive Vice President |
Feb 10 '25 |
Option Exercise |
79.54 |
9,986 |
794,286 |
18,162 |
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):